CDC Endorses Booster Shots for Millions of Americans
Recommendations came just one day after the FDA authorized boosters for several vulnerable groups at least six months after the second dose
Physician’s Briefing Weekly Coronavirus Roundup
Guillain-Barré Syndrome May Be Triggered by SARS-CoV-2 Infection
During study period, 22 percent with GBS had confirmed or probable SARS-CoV-2 infection; patients had uniform neurologic features
FDA Approves Pfizer Booster Shots for Seniors, High-Risk Americans
Exactly who qualifies as high risk because of health or work reasons is not yet clear
HPV Vaccine Will Have Modest Impact on Oropharynx Cancer Incidence by 2045
However, reductions in oropharynx cancer incidence should be seen among young and middle-aged adults
Uptake Low for Monoclonal Antibodies for COVID-19
Use peaked in January and declined in early 2021, at the time of the vaccine rollout
COVID-19 Does Not Seem to Impact Lung Function in Young People
No statistically significant deterioration in lung function seen following COVID-19, regardless of severity
Robotic Gastrectomy for Gastric Cancer Does Not Cut Postop Infections
But overall incidence of postoperative complications significantly lower with robotic versus laparoscopic gastrectomy
CDC Expert Panel to Weigh In on Vaccine Boosters
Panel will deliberate which high-risk groups should get a booster shot
U.S. to Buy 500 Million More COVID-19 Vaccine Doses for Global Donation
Some 160 million shots from the United States have been given to more than 100 countries
